Insider Transactions in Q1 2025 at Sutro Biopharma, Inc. (STRO)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 05
2025
|
Edward C Albini CFO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
3,594
-2.65%
|
$3,594
$1.36 P/Share
|
|
Mar 05
2025
|
Edward C Albini CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+6.06%
|
-
|
|
Mar 05
2025
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,594
-3.63%
|
$3,594
$1.36 P/Share
|
|
Mar 05
2025
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+8.12%
|
-
|
|
Mar 05
2025
|
William J Newell CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,708
-2.24%
|
$6,708
$1.36 P/Share
|
|
Mar 05
2025
|
William J Newell CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+5.9%
|
-
|
|
Mar 04
2025
|
Edward C Albini CFO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
3,748
-2.87%
|
$3,748
$1.42 P/Share
|
|
Mar 04
2025
|
Edward C Albini CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
9,125
+6.53%
|
-
|
|
Mar 04
2025
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,748
-3.99%
|
$3,748
$1.42 P/Share
|
|
Mar 04
2025
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,125
+8.85%
|
-
|
|
Mar 04
2025
|
Jane Chung Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,334
-2.32%
|
$2,334
$1.42 P/Share
|
|
Mar 04
2025
|
Jane Chung Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,875
+7.26%
|
-
|
|
Mar 04
2025
|
William J Newell CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,136
-3.82%
|
$11,136
$1.42 P/Share
|
|
Mar 04
2025
|
William J Newell CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
31,125
+9.64%
|
-
|
|
Mar 01
2025
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,327
-8.93%
|
$8,327
$1.59 P/Share
|
|
Mar 01
2025
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,275
+10.25%
|
-
|
|
Mar 01
2025
|
Jane Chung Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,450
-9.25%
|
$9,450
$1.59 P/Share
|
|
Mar 01
2025
|
Jane Chung Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,875
+13.91%
|
-
|
|
Mar 01
2025
|
Edward C Albini CFO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
10,320
-7.83%
|
$10,320
$1.59 P/Share
|
|
Mar 01
2025
|
Edward C Albini CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
25,125
+9.0%
|
-
|
|
Mar 01
2025
|
Hans Peter Gerber CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,621
-13.06%
|
$4,621
$1.59 P/Share
|
|
Mar 01
2025
|
Hans Peter Gerber CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+24.13%
|
-
|
|
Mar 01
2025
|
William J Newell CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
25,203
-8.82%
|
$25,203
$1.59 P/Share
|
|
Mar 01
2025
|
William J Newell CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
65,500
+10.81%
|
-
|
|
Mar 01
2025
|
Anne Elizabeth Borgman CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,621
-8.01%
|
$4,621
$1.59 P/Share
|
|
Mar 01
2025
|
Anne Elizabeth Borgman CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+16.31%
|
-
|
|
Mar 01
2025
|
Venkatesh Srinivasan CHIEF TECH OP OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,672
-10.84%
|
$4,672
$1.59 P/Share
|
|
Mar 01
2025
|
Venkatesh Srinivasan CHIEF TECH OP OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,375
+12.43%
|
-
|
|
Feb 28
2025
|
Anne Elizabeth Borgman CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,405
-24.9%
|
$15,405
$1.59 P/Share
|
|
Feb 28
2025
|
Anne Elizabeth Borgman CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+37.74%
|
-
|